Literature DB >> 30994024

MAPK pathway: a potential target for the treatment of non-small-cell lung carcinoma.

Rajesh Pradhan1, Gautam Singhvi1, Sunil Kumar Dubey1, Gaurav Gupta2, Kamal Dua3,4,5.   

Abstract

Entities:  

Keywords:  EGFR; MAPK; MAPK pathway; RAS; apoptosis; cancer; cell proliferation; epidermal growth factor receptor; lung cancer; non-small-cell lung carcinoma

Year:  2019        PMID： 30994024     DOI： 10.4155/fmc-2018-0468

Source DB:  PubMed          Journal:  Future Med Chem        ISSN： 1756-8919            Impact factor:   3.808


× No keyword cloud information.
  9 in total

1.  Molecular mechanism of Rhubarb in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking technology.

Authors:  Ye-Ru Tan; Yu Lu
Journal:  Mol Divers       Date:  2022-08-06       Impact factor: 3.364

2.  Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer.

Authors:  Yinjie Gao; Michelle M Stein; Matthew Kase; Amy L Cummings; Ramit Bharanikumar; Denise Lau; Edward B Garon; Sandip P Patel
Journal:  Cancer Immunol Immunother       Date:  2022-07-26       Impact factor: 6.630

Review 3.  PD-1/PD-L1 pathway: current researches in cancer.

Authors:  Yanyan Han; Dandan Liu; Lianhong Li
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

4.  Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation.

Authors:  Zhenjie Zhuang; Tong Lin; Zhanhua Liu; Lizhu Lin; Lixia Luo; Weixin Zhou; Junmao Wen; Haifu Huang
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

Review 5.  Role of platelet rich plasma mediated repair and regeneration of cell in early stage of cardiac injury.

Authors:  Syed Sarim Imam; Fahad A Al-Abbasi; Salman Hosawi; Muhammad Afzal; Muhammad Shahid Nadeem; Mohammed M Ghoneim; Sultan Alshehri; Sami I Alzarea; Ali Alquraini; Gaurav Gupta; Imran Kazmi
Journal:  Regen Ther       Date:  2022-02-15       Impact factor: 3.419

Review 6.  Overview of Ca2+ signaling in lung cancer progression and metastatic lung cancer with bone metastasis.

Authors:  Manh Tien Tran
Journal:  Explor Target Antitumor Ther       Date:  2021-06-28

7.  Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression.

Authors:  Yuanyong Wang; Rongjian Xu; Dongyang Zhang; Tong Lu; Wanpeng Yu; Yang Wo; Ao Liu; Tianyi Sui; Jian Cui; Yi Qin; Yanting Dong; Xiaoliang Leng; Dezhi Kong; Wenxing Du; Zhangfeng Huang; Wenhao Su; Tianxiang Yuan; Xiao Sun; Jianxun Wang; Wenjie Jiao
Journal:  Transl Lung Cancer Res       Date:  2019-12

8.  ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.

Authors:  Katarzyna Bogucka; Federico Marini; Sebastian Rosigkeit; Janine Schloeder; Helmut Jonuleit; Kerstin David; Margarita Schlackow; Krishnaraj Rajalingam
Journal:  Cancer Gene Ther       Date:  2020-10-17       Impact factor: 5.987

Review 9.  Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway.

Authors:  Anisha S Jain; Ashwini Prasad; Sushma Pradeep; Chandan Dharmashekar; Raghu Ram Achar; Silina Ekaterina; Stupin Victor; Raghavendra G Amachawadi; Shashanka K Prasad; R Pruthvish; Asad Syed; Chandan Shivamallu; Shiva Prasad Kollur
Journal:  Front Oncol       Date:  2021-10-06       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.